Mylan Laboratories Limited (Sterile Products Division) recalls

FDA enforcement reports naming Mylan Laboratories Limited (Sterile Products Division) as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Oct 16, 2019

Severity

Oct 16, 2019Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institution…Drug · Mylan Laboratories Limited (Sterile Products Division)Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.Class II